Chinese | English | Japanese

Home
About Enbridge
Products
Services
Blogs
Contact Us

Message

EnBridge PharmTech

BLOGS

Home

CPHI JAPAN 2024

2024

In 2023 Enbridge Pharmtech attended CPHI Japan and Thailand

2024

In 2023 Jeff Dong Attended Marathon Twice (21.0975KM and 42.195KM)

In the year of 2023, Jeff Dong attended Marathon twice. He finished 21.0975KM and 42.195KM and got good score medals.

2024

Cooperation between Enbridge and School of Chemistry and Chemical Engineering Nanjing University

Professor Zuo and Professor Li work in State Key Laboratory of Coordination Chemistry School of Chemistry and Chemical Engineering Nanjing University. They have excellent innovation ability and persistent research attitude.

2019

Phytic Acid and Sodium Phytate Introduction

“High-quality products, cost-effective prices, best reputation and professional services” is the managing motto of our company. We are looking forward to making mutual benefit with all of our cooperators.

2019

Yangshan Half Marathon-Exercises Keep You Healthy And Fit

Regular exercise and physical activity make us stay healthy, strong and many benefits for our body and brain.

2019

2017 CPHI Frankfurt (Oct.24, 2017-Oct. 26,2017)

During CPHI Frankfurt (Oct.24, 2017-Oct. 26,2017), our company met our good clients and potential new clients there. We had a fruitful meets and we knew the clients' request well.

2017

2016 CPHI Worldwide, Barcelona (Oct.04-06)

Our company participated in CPHI Worldwide, Barcelona, Spain (Oct. 4-6, 2016), booth No. was 7H52. Our company had fruitful meetings with good clients. Thanks for all the clients' visit!

2016

< 1 2 >

Nutritional ingredients

Quick Navigation

Contact Us

Address: Rm502, Bldg37, Huaqing Creative Park, No.33, Zhihui Road, Huishan District, Wuxi City, Jiangsu Province,P.R.China

TEL: 0086-510-83591909

E-MAIL: info@enbridgepharm.com

Disclaimer:

Patent-protected products are intended for research and development purposes only, and may not be sold in countries or regions where patent protection exists. The buyer assumes the risk and responsibility of patent infringement.